Figure 3From: Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysisEGFR overexpression and amplification: prognostic impact on DFS and OS. CISH, chromogenic in situ hybridization; DFS, disease-free survival; EGFR, epidermal growth factor receptor; OS, overall survival.Back to article page